Drug repositioning in cancer: The current situation in Japan

Cancer is a leading cause of death worldwide, and the incidence continues to increase. Despite major research aimed at discovering and developing novel and effective anticancer drugs, oncology drug development is a lengthy and costly process, with high attrition rates. Drug repositioning (DR, also r...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Takaaki, Tsuruda, Yusuke, Matsumoto, Yoshihiro, Uchida, Hiroki, Nakayama, Keiichi I., Mimori, Koshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156828/
https://www.ncbi.nlm.nih.gov/pubmed/31957175
http://dx.doi.org/10.1111/cas.14318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156828/
https://www.ncbi.nlm.nih.gov/pubmed/31957175
http://dx.doi.org/10.1111/cas.14318

Ejemplares similares